Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

JAK inhibitors show promise in treating difficult skin diseases.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Three compounds from Dadap leaves may help treat hair loss.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

JAK inhibitors are effective and safe for treating severe alopecia areata.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.